Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 3
2012 2
2014 2
2015 2
2016 5
2017 8
2018 4
2019 6
2020 11
2021 17
2022 13
2023 4
2024 6
2025 9
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy.
Karali M, Testa F, Di Iorio V, Torella A, Zeuli R, Scarpato M, Romano F, Onore ME, Pizzo M, Melillo P, Brunetti-Pierri R, Passerini I, Pelo E, Cremers FPM, Esposito G, Nigro V, Simonelli F, Banfi S. Karali M, et al. Among authors: di iorio v. Sci Rep. 2022 Dec 2;12(1):20815. doi: 10.1038/s41598-022-24636-1. Sci Rep. 2022. PMID: 36460718 Free PMC article.
Reply.
Newman H, Perlman I, Pras E, Rozenberg A, Ben-Yosef T, Iovino C, Simonelli F, Di Iorio V, Rotenstreich Y, Katzburg E, Ehrenberg M, Iglicki M, Zur D. Newman H, et al. Among authors: di iorio v. Retina. 2022 Oct 1;42(10):e49. doi: 10.1097/IAE.0000000000003564. Retina. 2022. PMID: 36129272 No abstract available.
Efficacy, toxicity, and clinical outcomes of 177Lu-PSMA-617 radioligand therapy at 5.5 GBq per cycle in patients with advanced castration-resistant prostate cancer: a prospective, single arm, phase II study.
Marini I, Giunta EF, Nicolini S, Grassi I, Foca F, Sarnelli A, Di Iorio V, Vizza L, Giani E, Celli M, Monti M, Severi S, De Giorgi U, Borgia F, Paganelli G, Matteucci F, Sansovini M. Marini I, et al. Among authors: di iorio v. Eur J Nucl Med Mol Imaging. 2026 Apr;53(5):3023-3033. doi: 10.1007/s00259-025-07661-w. Epub 2025 Nov 27. Eur J Nucl Med Mol Imaging. 2026. PMID: 41307700 Free PMC article. Clinical Trial.
PSMA for HCC: a new frontier in precision medicine for liver cancer?
Caroli P, Rossetti V, Sansovini M, Fantini L, Marini I, Nicolini S, Grassi I, Matteucci F, Di Iorio V, Celli M. Caroli P, et al. Among authors: di iorio v. Cancer Treat Res Commun. 2026;47:101169. doi: 10.1016/j.ctarc.2026.101169. Epub 2026 Mar 5. Cancer Treat Res Commun. 2026. PMID: 41831332 Free article. Review.
Theragnostic in neuroendocrine tumors.
Marini I, Sansovini M, Bongiovanni A, Nicolini S, Grassi I, Ranallo N, Monti M, DI Iorio V, Germanò L, Caroli P, Sarnelli A, Paganelli G, Severi S. Marini I, et al. Among authors: di iorio v. Q J Nucl Med Mol Imaging. 2021 Dec;65(4):342-352. doi: 10.23736/S1824-4785.21.03426-9. Epub 2021 Dec 9. Q J Nucl Med Mol Imaging. 2021. PMID: 34881852
Recommendations on the Clinical Application and Future Potential of α-Particle Therapy: A Comprehensive Review of the Results from the SECURE Project.
Di Iorio V, Sarnelli A, Boschi S, Sansovini M, Genovese RM, Stefanescu C, Ghizdovat V, Jalloul W, Young J, Sosabowski J, Kolenc P, Roberts R, With G, Visvikis D, Mikolajczak R. Di Iorio V, et al. Pharmaceuticals (Basel). 2025 Oct 18;18(10):1578. doi: 10.3390/ph18101578. Pharmaceuticals (Basel). 2025. PMID: 41155690 Free PMC article. Review.
86 results